COVID-19 vaccines
The development of COVID-19 vaccines has led to promising results, with multiple vaccines demonstrating high efficacy against the virus. The vaccines, developed by various companies and institutions, have taken different approaches to creating immunity against COVID-19. COVID-19 vaccines have undergone extensive testing, with some showing remarkable results. Key Takeaways: * Pfizer
COVID-19 vaccines
BP's fourth-quarter results, out on Tuesday, will be followed by US oil giants ExxonMobil and Conoco-Phillips, as the world's largest energy companies navigate a challenging landscape. With the global economy fighting to recover from the COVID-19 pandemic, investors will be keenly watching for signs of a
COVID-19 vaccines
The European Union has stepped up its pressure on pharmaceutical companies that received EU aid to develop coronavirus vaccines, warning them to deliver shots on schedule at a time when infections are surging and many EU member states are struggling to roll out vaccines efficiently. The EU has invested heavily
COVID-19 vaccines
As the world anxiously awaits Johnson & Johnson's phase 3 COVID-19 vaccine data, the company is gearing up for regulatory filings and a global rollout. With orders for hundreds of millions of doses pending, J&J executives have expressed confidence in meeting their 2021 supply commitments. The
COVID-19 vaccines
Grocery retailers are playing a critical role in the national effort to distribute COVID-19 vaccines, with several major chains outlining their vaccination plans. Walmart, the largest grocery retailer in the US, has announced plans to offer COVID-19 vaccines 7 days a week at its pharmacies, with a goal of delivering
COVID-19 vaccines
As the COVID-19 pandemic rages on, the World Health Organization (WHO) is growing increasingly frustrated with the delay in vaccine distribution, particularly in poorer nations. WHO Director-General Tedros Adhanom Ghebreyesus has accused drug manufacturers of prioritizing regulatory approval in rich countries, where profits are highest, over submitting full dossiers to
COVID-19 vaccines
Australia's chief medical officer, Professor Paul Kelly, has defended the country's decision to secure 54m doses of the Covid-19 vaccine made by Oxford University and pharmaceutical company AstraZeneca, despite concerns that it may not be effective enough to achieve herd immunity. The vaccine has been criticized
COVID-19 vaccines
John and Jean Hutchinson, an elderly couple in their 80s, and Arthur Wilkinson, a 87-year-old pensioner, have shared their positive experiences with receiving the Covid-19 vaccination at special clinics in their area. The couple praised the NHS frontline staff for their efficiency and kindness, while Arthur described the experience as
COVID-19 vaccines
The Indian government has granted final approval to Covishield and Covaxin, two COVID-19 vaccines manufactured by Serum Institute of India and Bharat Biotech Ltd, respectively, for "emergency use" against the coronavirus. The Drugs Controller General of India (DCGI) formally announced the approval, which follows a recommendation by the
COVID-19 vaccines
As India begins its nationwide mass inoculation drive against COVID-19, the country's vaccine approval process has come under scrutiny. The Drug Controller General of India (DCGI) has approved two vaccines for restricted emergency use: Serum Institute of India's Covishield and Bharat Biotech's Covaxin. However,
COVID-19 vaccines
Indian authorities have approved two coronavirus vaccines for emergency use, granting permission to Serum and Bharat Biotech to manufacture the jabs. The approval comes as India, with a population of 1.3 billion, prepares to inoculate 300 million people on a priority list this year. The move is seen as
COVID-19 vaccines
British drugs group AstraZeneca and the University of Oxford have achieved a "winning formula" for their Covid-19 vaccine, according to the company's chief executive Pascal Soriot. The vaccine, currently being evaluated by Britain's independent medicines regulator, provides 100 percent protection against severe Covid disease
